Case Report: HER2-positive vulvar Paget disease achieving long-term control with trastuzumab-based systemic therapy plus radiotherapy

HER2-targeted therapy combined with chemotherapy and radiotherapy is a promising treatment strategy for HER2-positive, inoperable or recurrent VPD.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-01-26
DOI
https://doi.org/10.3389/fmed.2026.1740493
Primary Topic
Cancer and Skin Lesions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: HER2-positive vulvar Paget disease achieving long-term control with trastuzumab-based systemic therapy plus radiotherapy

Qinyang Chen, Jian Zhang, Xiaodong Peng
Frontiers in Medicine
Cancer and Skin Lesions
article

Case Report: HER2-positive vulvar Paget disease achieving long-term control with trastuzumab-based systemic therapy plus radiotherapy

Qinyang Chen, Jian Zhang, Xiaodong Peng
article en

Abstract

HER2-targeted therapy combined with chemotherapy and radiotherapy is a promising treatment strategy for HER2-positive, inoperable or recurrent VPD.

Frontiers in MedicineVol. 13
Sichuan University (CN), West China Second University Hospital of Sichuan University (CN), West China Hospital of Sichuan University (CN), Chengdu Second People's Hospital (CN)
Chengdu Science and Technology Program
Openalex Percentile: Top 77%
Cancer and Skin Lesions
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.